| Website | newleafsym.com |
| Phone | 314-993-4411 |
| info@newleafsym.com | |
| Employees | |
| Founded | 1999 |
| TOTAL | $7M |
| FUNDING TOTAL | $7M |
| Series A, 1/13 RockPort Capital Partners Open Prairie Ventures Pangaea Ventures | $7M |
NewLeaf Symbiotics was formed in 2012 to develop and commercialize one of the most prevalent, beneficial bacteria found in nature: PPFMs (Pink Pigmented Facultative Methylotrophs). NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria. NewLeaf Symbiotics has also filed its own related patents, and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.
